CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $98,000 | -56.6% | 20,000 | 0.0% | 0.02% | -55.9% |
| Q4 2021 | $226,000 | -22.3% | 20,000 | 0.0% | 0.03% | -55.3% |
| Q3 2021 | $291,000 | +24.9% | 20,000 | 0.0% | 0.08% | +46.2% |
| Q2 2021 | $233,000 | -4.5% | 20,000 | 0.0% | 0.05% | -5.5% |
| Q1 2021 | $244,000 | -2.4% | 20,000 | 0.0% | 0.06% | -9.8% |
| Q4 2020 | $250,000 | -16.9% | 20,000 | 0.0% | 0.06% | -26.5% |
| Q3 2020 | $301,000 | – | 20,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |